Xiaohui Wang

Xiaohui Wang

Auto-generated profile, based on publicly available information

Xiaohui Wang

Department of Neurology Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Frontiers of Structural and Civil Engineering
Verified
Journal Article
Closed access
PDF file
Wenjun ZhangWenjun Zhang
Wenjun Zhang
WZWuqi Zhang
Wuqi Zhang
GZGaole Zhang
Gaole Zhang
JHJun Huang
Jun Huang
MLMinggeng Li
Minggeng Li
Xiaoming GuanXiaoming Guan
Xiaoming Guan

11 March 2025 in Pediatric Investigation
Verified
Journal Article
Open access
XWXiaohui Wang
Xiaohui Wang
TJTaoyun Ji
Taoyun Ji
MLMaomao Liu
Maomao Liu
XWXiaofei Wang
Xiaofei Wang
ZYZhixian Yang
Zhixian Yang
QWQun Wang
Qun Wang
Importance: Perampanel (PER) is used less extensively in children than in adults. Currently, there is a lack of data from PER clinical studies with large sample sizes in Chinese children and adolescents with epilepsy, especially those with refractory epilepsy.Objective: To evaluate the effectiveness, retention, and safety of PER in the treatment of children and adolescents with epilepsy in China.Methods: This was a multicenter, prospective, observational study. Children and adolescents with epilepsy who received PER as adjunctive therapy were included. The primary effectiveness endpoint was the proportion of patients achieving a ≥50% reduction in seizure frequency after 6 months of treatment compared to baseline. The secondary effectiveness endpoints included retention and seizure‐free rates. The safety outcome was the incidence of treatment‐emergent adverse events (TEAEs).Results: A total of 240 patients with epilepsy were enrolled in the study. Prior to initiating PER treatment, approximately 87.9% of them took two or more antiseizure medications. After a 6‐month treatment regimen with PER, 70.4% of the patients experienced a reduced seizure frequency of at least 50%, and 22.1% achieved complete seizure freedom. The retention rate was 90.2%. TEAEs were reported by 89 patients, leading to the discontinuation of PER in seven cases. No severe TEAEs were observed in this study.Interpretation: Under routine clinical conditions, PER demonstrated good effectiveness and retention in Chinese children with epilepsy, particularly in those with refractory epilepsy.